The novel risk score model for predicting the poor anticoagulation control in patients with atrial fibrillation taking warfarin

Methavigul, Komsing; Krittayaphong, Rungroj

doi:10.2478/abm-2025-0013

Abstract

Background

Previous trials have shown that the C-statistics of SAMe-TT₂R₂ score in the prediction of suboptimal time in therapeutic range (TTR) is very low.

Objectives

To propose the novel risk score model for predicting the poor anticoagulation control in atrial fibrillation (AF) patients compared with the SAMe-TT₂R₂ score.

Methods

We prospectively recruited AF patients from 27 hospitals between 2014 and 2017 in the COOL AF Thailand registry. The poor anticoagulation control was defined as TTR <65%. Multivariate logistic regression analysis was performed for the prediction of poor anticoagulation control. The novel risk score model was then generated. Receiver operating characteristic (ROC) curve analysis was performed to calculate the C-statistics and to compare between the novel risk score model and the SAMe-TT₂R₂ score. Net Reclassification Index (NRI) and Integrated Discrimination Index (IDI) were performed.

Results

Of 3,461 patients, 2,233 patients taking warfarin having available TTR data were retrieved. There were 1,432 patients having poor anticoagulation control (TTR < 65%) and 801 patients having good anticoagulation control (TTR ≥ 65%). Symptomatic AF, diabetes, heart failure, and a history of bleeding were associated with increased risk while obesity, AF duration, and paroxysmal AF were associated with decreased risk of poor anticoagulation control. SHOB-D₂AF score was created. The C-statistics of SHOB-D₂AF score was greater than the SAMe-TT₂R₂ score (0.584 vs 0.506, P < 0.001). NRI of the SHOB-D₂AF score was 17.82% compared with the SAMe-TT₂R₂ score.

Conclusions

SHOB-D₂AF score was the novel risk score which was better than the SAMe-TT₂R₂ score in predicting poor anticoagulation control.

References

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.Eur Heart J. 2021; 42:373–498.
Search in Google Scholar Back to article
January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019; 74:104–32.
Search in Google Scholar Back to article
Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, et al. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost. 2022; 122:20–47.
Search in Google Scholar Back to article
Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, et al. Antithrombotic therapy for atrial fibrillation: CHEST Guideline and Expert Panel Report. Chest. 2018; 154:1121–201.
Search in Google Scholar Back to article
Krittayaphong R, Winijkul A, Methavigul K, Wongtheptien W, Wongvipaporn C, Wisaratapong T, et al. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study. BMC Cardiovasc Disord. 2018; 18:174. doi: 10.1186/s12872-018-0911-4
Open DOI Search in Google Scholar Back to article
Methavigul K, Boonyapisit W. Optimal INR level in Thai atrial fibrillation patients who were receiving warfarin for stroke prevention in Thailand. J Med Assoc Thai. 2014; 97:1274–80.
Search in Google Scholar Back to article
Methavigul K. Use of SAMe-TT₂R₂ score to predict the quality of anticoagulation control in patients with atrial fibrillation receiving warfarin in Thailand. J Med Assoc Thai. 2020; 103:548–52.
Search in Google Scholar Back to article
Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P, et al. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes. 2008; 1:84–91.
Search in Google Scholar Back to article
Haas S, Ten Cate H, Accetta G, Angchaisuksiri P, Bassand JP, Camm AJ, et al. Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF Registry. PLoS One. 2016; 11:e0164076. doi: 10.1371/journal.pone.0164076
Open DOI Search in Google Scholar Back to article
Krittayaphong R, Chantrarat T, Rojjarekampai R, Jittham P, Sairat P, Lip GYH. Poor time in therapeutic range control is associated with adverse clinical outcomes in patients with non-valvular atrial fibrillation: a report from the nationwide COOL-AF registry. J Clin Med. 2020; 9:1698. doi: 10.3390/jcm9061698
Open DOI Search in Google Scholar Back to article
Apostolakis S, Sullivan RM, Olshansky B, Lip GYH. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score. Chest. 2013; 144:1555–63.
Search in Google Scholar Back to article
Lip GYH, Haguenoer K, Saint-Etienne C, Fauchier L. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation. Chest. 2014; 146:719–26.
Search in Google Scholar Back to article
Proietti M, Lane DA, Lip GY. Relation of the SAMe-TT₂R₂ score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: observations from the SPORTIF trials. Int J Cardiol. 2016; 216:168–72.
Search in Google Scholar Back to article
Chan PH, Hai JJ, Chan EW, Li WH, Tse HF, Wong IC, et al. Use of the SAMe-TT₂R₂score to predict good anticoagulation control with warfarin in Chinese patients with atrial fibrillation: relationship to ischemic stroke incidence. PLoS One. 2016; 11:e0150674. doi: 10.1371/journal.pone.0150674
Open DOI Search in Google Scholar Back to article
Bernaitis N, Ching CK, Chen L, Hon JS, Teo SC, Davey AK, et al. The sex, age, medical history, treatment, tobacco use, race risk (SA Me TT(2)R(2)) score predicts warfarin control in a Singaporean population. J Stroke Cerebrovasc Dis. 2017; 26:64–9.
Search in Google Scholar Back to article
Methavigul K. Proportion of Thai patients with atrial fibrillation receiving warfarin with labile INR in each group of SAMeTT₂R₂ score. J Med Assoc Thai. 2018; 101:189–93.
Search in Google Scholar Back to article
Krittayaphong R, Winijkul A, Pirapatdit A, Chiewvit P, Komoltri C, Boonyapisit W, et al. SAMe-TT₂R₂score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation. Singapore Med J. 2020; 61:641–6.
Search in Google Scholar Back to article
Zhang H, Yang Y, Zhu J. The SAMe-TT(2)R(2) score: far from clinical application. Chest. 2014; 145:418–9.
Search in Google Scholar Back to article
Methavigul K, Yindeengam A, Krittayaphong R. Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TT(2)R(2) score. BMC Cardiovasc Disord. 2023; 23:43. doi: 10.1186/s12872-023-03053-w
Open DOI Search in Google Scholar Back to article
Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993; 69:236–9.
Search in Google Scholar Back to article
Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008; 27:157–72; discussion 207-112.
Search in Google Scholar Back to article